Boehringer Ingelheim

Topics • Technology

Boehringer, Vitae ink $242 Million Alzheimer’s Deal

Top-Feature

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

INOSIM GmbH

Predictive Simulation in Pharma Production

Book

Innovation Management in Sustainable Chemistry

Comprehensive resource on sustainable chemistry, bridging the skill gap between academic science education and innovation and entrepreneurship

Oracle Germany

Bayer AG

Frost & Sullivan

QUANTRO Therapeutics GmbH

Roche Group

GlobalData

JMP Statistical Discovery / SAS Institute GmbH

PP Consulting

C² PHARMA

CHEManager International c/o Wiley-VCH GmbH

SchüllerConsulting

BearingPoint GmbH

ACIB Austrian Centre of Industrial Biotechnology

DCAT - Drug, Chemical & Associated Technologies Association

LISA Life Science Austria

Eli Lilly and Company

Thomson Reuters

Boehringer Ingelheim

Boehringer Ingelheim

Europe Backs New Dual-Action Novartis Lung Drug

Eli Lilly Broadens Diabetes Offer

GlaxoSmithKline Unit Joins Patent Pool for AIDS Drugs

Boehringer Ingelheim Ohio Subsidiary Enters Consent Decree

Global Meets Local in Austria

Eli Lilly Banks on Cost Controls for Higher 2013 Profit

Drugmaker Boehringer Settles Marketing Claim for $95 Million

Maturing Belgian Biotechs Outshine European Peers

Stick to Your Strengths with Biosimilars

Thriving Generics

U.S. Medicine Spending Rose to $320 Billion Last Year

Bayer Sees Healthcare Business Driving Growth

Peter Pollak on the World of Fine Chemicals

Innovation Expected from API Manufacturers

Amylin Sues Lilly over Diabetes Partnership

Merck, Sanofi Animal Health JV to Close Later Than Expected

Novartis CEO Joe Jimenez: Animal Health Acquisition Makes Sense

Oracle’s Agile PLM Reorganizes Pharma, From Lab to Launch

Amgen To Sell California Drug Plant To Boehringer

Eli Lilly, Boehringer Ingelheim in Drug-Development Alliance

Fresenius Could Be in the Mood for Acquisitions

Abbott to Pay $121.5 Million in False Claims Settlement

Live And Learn

Pfizer Selling China Swine Vaccine Unit to Harbin Pharma

Pfizer Exec Jumps Ship to Head AstraZeneca's R&D

Cost, Quality And Reliability

Bayer Still Out To Buy, Not Sell, Vet Businesses

Boehringer to Buy Rest of Japan's SSP

Drugmaker Boehringer Ingelheim Not For Sale

Boehringer, Vitae ink $242 Million Alzheimer’s Deal

Top-Feature

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Upcoming Virtual Events

Predictive Simulation in Pharma Production

Book

Innovation Management in Sustainable Chemistry

Boehringer Ingelheim

Top-Feature

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Upcoming Virtual Events

Predictive Simulation in Pharma Production

Book

Newsletter & e-edition